Valuation: Cellink AB

Market Cap 1.45B 148M 128M 121M 110M 206M 14.2B 208M 558M 7.2B 556M 544M 22.9B P/E 2026 *
-6.37x
P/E 2027 * -11.5x
Enterprise Value 1.38B 141M 122M 115M 105M 196M 13.52B 198M 531M 6.86B 530M 518M 21.81B EV / Sales 2026 *
0.85x
EV / Sales 2027 * 0.76x
Free-Float
69.88%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 51 2026-08-31
Director of Finance/CFO 56 2026-02-28
Chief Operating Officer - 2026-01-06
Director TitleAgeSince
Director/Board Member 70 2019-12-17
Director/Board Member 37 2015-02-28
Director/Board Member - 2026-05-06
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 149M
+0.62%-0.03%+27.98%+19.00% 225B
+1.55%-2.12%+6.95%-19.82% 141B
+2.38%+3.07%-15.95%+24.43% 130B
+4.82%-5.75%-56.14%-14.87% 62.29B
+1.99%+0.96%-18.12%-13.93% 49.39B
+1.36%-4.87%+10.25%+15.54% 48.63B
-0.09%-2.69%+19.12%+27.79% 41.42B
+0.41%+0.15%+38.80%+50.73% 40.12B
+2.16%-2.35%-17.45%+51.04% 31.23B
Average +1.52%-2.00%-0.51%+15.54% 85.52B
Weighted average by Cap. +1.58%-1.31%+4.05%+11.18%

Financials

2026 *2027 *
Net sales 1.62B 166M 144M 136M 123M 231M 15.92B 233M 625M 8.08B 624M 610M 25.67B 1.69B 173M 150M 141M 128M 240M 16.54B 242M 649M 8.39B 648M 634M 26.68B
Net income -227M -23.24M -20.14M -19.01M -17.24M -32.35M -2.23B -32.58M -87.47M -1.13B -87.3M -85.38M -3.59B -126M -12.9M -11.18M -10.55M -9.57M -17.95M -1.24B -18.08M -48.55M -627M -48.46M -47.39M -1.99B
Net Debt -69M -7.07M -6.12M -5.78M -5.24M -9.83M -677M -9.9M -26.59M -344M -26.54M -25.95M -1.09B -166M -17M -14.73M -13.9M -12.61M -23.65M -1.63B -23.83M -63.97M -826M -63.84M -62.43M -2.63B
Logo Cellink AB
BICO Group AB, previously Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!